Octapharma

This study is testing a drug called Atenativ for adults having heart surgery using a heart-lung machine. Some patients don't respond well to the standard blood thinner (heparin) needed during this surgery, which can be dangerous. The trial will see if Atenativ can safely restore …

This study is testing a medication called OCTAPLEX to see how well it can quickly stop life-threatening or serious bleeding in people who are taking common blood-thinning pills (like rivaroxaban or apixaban). Researchers are comparing a low dose to a high dose in about 260 adults…

This study follows 200 patients with severe hemophilia A who are just starting treatment with one of three specific clotting factor products. Researchers will observe how well these treatments control bleeding in real-world settings and monitor for safety issues, particularly foc…

This study is testing a medication called Atenativ to see if it can safely prevent dangerous blood clots in people with a rare inherited condition that makes them prone to clotting. It focuses on adults who need high-risk surgery or are about to give birth, as these events greatl…

This study aims to see how well the medication Nuwiq works to prevent bleeding during and after major surgery in patients with severe hemophilia A who are already taking emicizumab. The research will involve about 28 male patients aged 12 and older who are scheduled for major sur…

This study is testing an intravenous treatment made from human plasma (C1-INH concentrate) for people with a rare genetic condition called hereditary angioedema (HAE). The goal is to see if this treatment can quickly relieve painful swelling attacks and also prevent attacks befor…

This study is testing how well a medication called Nuwiq controls bleeding during and after major surgery in women and girls with hemophilia A. It will involve about 28 participants aged 12 and older who are scheduled for surgery. The main goal is to see if Nuwiq successfully pre…